Oral administration of berberine limits post-traumatic osteoarthritis development and associated pain via AMP-activated protein kinase (AMPK) in mice
- 21 October 2021
- journal article
- research article
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 30 (1) , 160-171
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01AR070222)
- U.S. Department of Veterans Affairs
This publication has 42 references indexed in Scilit:
- Linked decreases in liver kinase B1 and AMP-activated protein kinase activity modulate matrix catabolic responses to biomechanical injury in chondrocytesArthritis Research & Therapy, 2013
- The functions of TRPA1 and TRPV1: moving away from sensory nervesBritish Journal of Pharmacology, 2012
- Osteoarthritis: A disease of the joint as an organArthritis & Rheumatism, 2012
- Acute joint pathology and synovial inflammation is associated with increased intra-articular fracture severity in the mouse kneeOsteoarthritis and Cartilage, 2011
- Chondrocyte AMP-activated protein kinase activity suppresses matrix degradation responses to proinflammatory cytokines interleukin-1β and tumor necrosis factor αArthritis & Rheumatism, 2011
- ADAMTS-5 deficient mice do not develop mechanical allodynia associated with osteoarthritis following medial meniscal destabilizationOsteoarthritis and Cartilage, 2010
- Matrix metalloproteinase 13–deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte developmentArthritis & Rheumatism, 2009
- OsteoarthritisJournal of Cellular Physiology, 2007
- Osteoarthritis, an inflammatory disease: Potential implication for the selection of new therapeutic targetsArthritis & Rheumatism, 2001
- Effects of Stimulation of AMP-activated Protein Kinase on Insulin-like Growth Factor 1- and Epidermal Growth Factor-dependent Extracellular Signal-regulated Kinase PathwayJournal of Biological Chemistry, 2001